» Articles » PMID: 32723805

Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis

Abstract

Background And Objectives: The histopathologic classification for ANCA-associated GN distinguishes four classes on the basis of patterns of injury. In the original validation study, these classes were ordered by severity of kidney function loss as follows: focal, crescentic, mixed, and sclerotic. Subsequent validation studies disagreed on outcomes in the crescentic and mixed classes. This study, driven by the original investigators, provides several analyses in order to determine the current position of the histopathologic classification of ANCA-associated GN.

Design, Setting, Participants, & Measurements: A validation study was performed with newly collected data from 145 patients from ten centers worldwide, including an analysis of interobserver agreement on the histopathologic evaluation of the kidney biopsies. This study also included a meta-analysis on previous validation studies and a validation of the recently proposed ANCA kidney risk score.

Results: The validation study showed that kidney failure at 10-year follow-up was significantly different between the histopathologic classes (<0.001). Kidney failure at 10-year follow-up was 14% in the crescentic class versus 20% in the mixed class (=0.98). In the meta-analysis, no significant difference in kidney failure was also observed when crescentic class was compared with mixed class (relative risk, 1.15; 95% confidence interval, 0.94 to 1.41). When we applied the ANCA kidney risk score to our cohort, kidney survival at 3 years was 100%, 96%, and 77% in the low-, medium-, and high-risk groups, respectively (<0.001). These survival percentages are higher compared with the percentages in the original study.

Conclusions: The crescentic and mixed classes seem to have a similar prognosis, also after adjusting for differences in patient populations, treatment, and interobserver agreement. However, at this stage, we are not inclined to merge the crescentic and mixed classes because the reported confidence intervals do not exclude important differences in prognosis and because an important histopathologic distinction would be lost.

Citing Articles

ANCA-Associated Glomerulonephritis: Diagnosis and Therapy Proceedings of the Henry Shavelle Lectureship.

Ivkovic V, Windpessl M, Berke I, Geetha D, Callemeyn J, Norouzi S Glomerular Dis. 2025; 5(1):26-47.

PMID: 39991195 PMC: 11842095. DOI: 10.1159/000542925.


5th International Renal Pathology Conference in Zagreb, Croatia: Meeting Report.

Senjug P, Ljubanovic D Glomerular Dis. 2025; 5(1):19-25.

PMID: 39991194 PMC: 11842037. DOI: 10.1159/000542726.


Explainability of a Deep Learning-Based Classification Model for Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.

Wester Trejo M, Sadeghi M, Singh S, Mahmoodian N, Sharifli S, Hruskova Z Kidney Int Rep. 2025; 10(2):457-465.

PMID: 39990883 PMC: 11843110. DOI: 10.1016/j.ekir.2024.11.005.


Validation and modification of renal risk score for prediction of long-term kidney survival in patients with MPO-ANCA-associated glomerulonephritis.

Yang M, Liu X, Chen Y, Chen X, Xu F, Liu Z J Nephrol. 2024; 38(1):215-224.

PMID: 39576457 DOI: 10.1007/s40620-024-02134-z.


Course of paediatric ANCA-associated glomerulonephritis: advocating for an age-inclusive approach.

Barnini C, Oni L, Kronbichler A RMD Open. 2024; 10(3).

PMID: 39004433 PMC: 11253762. DOI: 10.1136/rmdopen-2024-004481.